Starling Oncology (STLN) closed at $3.50 on November 13, 2026, down 6.7% from the previous close, on volume of 22,640,495 shares (30-day average 2,608,146).
Data as of November 13, 2026.
13-Nov-2026
| # | Date | Strategy | Legs | Contracts |
|---|---|---|---|---|
| 1 | Nov 9, 2026 | Call Spread | 20-Nov-264 : 5 C | 2,000 |
| 2-3 | The next 2 largest trades are for Premium members. Start a 7-day free trial | |||
Ranked by contracts: multi-leg trades of 200 or more contracts on one day, through Nov 13, 2026. See the 10 largest for 30, 60 and 90 days
Starling Oncology Provides Investor Presentation Highlighting Growth
TipRanks (Thu, 12-Nov 9:14 AM ET)
Starling Oncology Reports Third Quarter 2026 Financial Results and Updates Full-Year 2026 Guidance
Globe Newswire (Thu, 5-Nov 4:06 PM ET)
Starling Oncology Announces Third Quarter 2026 Earnings Release Date and Conference Call
Globe Newswire (Mon, 26-Oct 9:00 AM ET)
Starling Oncology Leadership Highlights Recent and Upcoming Industry Conference Participation
Globe Newswire (Thu, 1-Oct 4:14 PM ET)
Starling Oncology to Participate in Wells Fargo Healthcare Conference
Globe Newswire (Mon, 24-Aug 9:00 AM ET)
Market Chameleon (Mon, 17-Aug 4:32 AM ET)
Globe Newswire (Mon, 17-Aug 8:00 AM ET)
STLN Ups Guidance for 2026 as Capitated Revenue Grows and Adjusted EBITDA Turns Positive
Market Chameleon (Fri, 7-Aug 3:06 AM ET)
Starling Oncology Inc provides oncology care services in community settings. Its services include cancer diagnosis and treatment, clinical trials, transfusion services, and other oncology care delivery models for patients.
Starling Oncology trades on the NASDAQ stock market under the symbol STLN.
As of November 13, 2026, STLN stock price declined to $3.50 with 22,640,495 million shares trading.
STLN has a beta of 5.94, meaning it tends to be more sensitive to market movements. STLN has a correlation of 0.24 to the broad based SPY ETF.
STLN has a market cap of $356.97 million. This is considered a Small Cap stock.
Last quarter Starling Oncology reported $170 million in Revenue and -$.13 earnings per share. This beat revenue expectation by $1 million and missed earnings estimates by -$.08.
The top ETF exchange traded funds that STLN belongs to (by Net Assets): VTI, IWM, VXF, VTWO, IWO.
STLN support price is $3.56 and resistance is $3.94 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that STLN shares will trade within this expected range on the day.
